PharmExec Blog
Follow Us
RSS
Bookstore
Monthly Archives: June 2012
Health Reform Declared Constitutional
It’s back to business for pharma and biotech companies.
The main result of the Supreme Court decision upholding the Affordable Care Act (ACA) is that it ends all the rampant speculation and uncertainty about the future shape of the U.S. healthcare system. Now healthcare providers, insurers, medical products makers, and government agencies can move forward with [...]
Future Boom in Chronic Cancer Patients Likely to Change the Face of Disease, suggest ASCO Findings
Patients who live for many years following a cancer diagnosis will likely require additional support, and a whole new kind of follow-up care.
by John Otrompke
Dramatic developments in studies of patients with advanced cancer suggest that the day may be coming within our lifetime when most cancer patients will experience the disease as a [...]
Congress Move Promptly to Finalize FDA User Fees
Legislation fails to establish a national track-and-trace system, but tackles shortages, orphans.
House and Senate leaders announced final agreement June 18, 2012 on legislation that authorizes industry user fees to support Food and Drug Administration regulatory programs. The bipartisan measure moved through Congress quickly with an eye to avoid getting tangled up in fallout from the [...]
Who's the More Innovative: CROs or Pharma?
CROs and pharma battled for the innovation crown at last week’s annual PCMG’s conference. Julian Upton reports.
It’s rather refreshing, in these gloomy economic times, to attend an event that bucks the trend for austerity, and the Pharmaceutical Contract Management Group (PCMG) annual conference last week certainly did that. For the last four years of its [...]
Posted in Global, Meetings, R&D Tagged conferenc, contracting, Events, innovation, mettings, outsorucing, PCMG 3 Comments
The Yin and Yang of the Court Decision on HCR